We assessed baseline knowledge of follow-on basal insulin and if an online, video-based, continuing medical education (CME) roundtable activity could improve the clinical knowledge and competence of primary care physicians (PCPs) and diabetologists/endocrinologists (D/Es) regarding follow-on basal insulin. A 3-question knowledge/competence and 1-question confidence linked pre-/post-assessment study design with McNemar’s chi-squared test (5% significance level, P <.05) and Cramer’s V (<0.no effect; 0.06-0.15 small effect; 0.16-0.30 medium effect; >0.30 large effect) assessed educational effect. The activity launched February 14, 2017, and data collected through March 20, 2017. PCPs (N=284) demonstrated a lower baseline knowledge level compared to D/Es (N=57): 9% of PCPs compared to 23% of D/Es correctly identified PK/PD data for follow-on insulin glargine 14% of PCPs compared to 30% of D/Es correctly identified a patient for whom follow-on basal insulin was a good therapeutic option Overall improvements were seen after participation in for both PCPs (n = 284; large effect of V= 0.329) and D/Es (n = 57; medium effect of V= 0.217). Improvements include: 56% more PCPs (P<.001) and 38% more D/Es (P<.001) accurately selected a patient for follow-on basal insulin use 30% more PCPs (P<.001) and 16% more D/Es (P=.082) correctly identified PK/PD data for follow-on insulin glargine 12% more PCPs (P=.001) and 10% more D/Es (P=.123) selected an effective strategy for overcoming a common barrier to insulin therapy 61% of PCPs and 37% of D/Es reported increased confidence switching patients with T2D from insulin glargine to follow-on insulin glargine This study demonstrates the success of online, video-based roundtable-style CME on improving clinical knowledge and competence of PCPs and D/Es related to follow-on basal insulin. As expected, PCPs had lower baseline knowledge compared to D/Es, and may need more foundational education related to newer therapeutic options for T2D.


A. Larkin: None. J. Dropkin: None. A. Le: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.